Yüklüyor......
Advances in preclinical approaches to Chagas disease drug discovery
INTRODUCTION: Chagas disease affects 8–10 million people worldwide, mainly in Latin America. The current therapy for Chagas disease is limited to nifurtimox and benznidazole, which are effective in treating only the acute phase of the disease but with severe side effects. Therefore, there is an unme...
Kaydedildi:
| Yayımlandı: | Expert Opin Drug Discov |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779130/ https://ncbi.nlm.nih.gov/pubmed/31411084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17460441.2019.1652593 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|